BDRX (Biodexa Pharmaceuticals) OCF Margin %: 0.00% (As of Dec. 2025)


BDRX Biodexa Pharmaceuticals PLC BDRX
45 GF Score
Price $2.54
GF Value $2.26
Valuation Fairly Valued
View Full Analysis

What is Biodexa Pharmaceuticals OCF Margin %?

Biodexa Pharmaceuticals BDRX -2.68% 45 OCF Margin % is 0.00% as of Dec. 2025. GuruFocus rates BDRX with a GF Score™ of 45/100 and a GF Value™ of $2.26 (Fairly Valued). Among 960 Biotechnology companies, Biodexa Pharmaceuticals ranks worse than 104166.56% on this metric.

OCF Margin % is calculated as Cash Flow from Operations divided by its Revenue. Biodexa Pharmaceuticals's Cash Flow from Operations for the six months ended in Dec. 2025 was $-3.06 Mil. Biodexa Pharmaceuticals's Revenue for the six months ended in Dec. 2025 was $0.00 Mil. Therefore, Biodexa Pharmaceuticals's OCF Margin % for the quarter that ended in Dec. 2025 was 0.00%.

As of today, Biodexa Pharmaceuticals's current OCF Yield % is -396.06%.

The historical rank and industry rank for Biodexa Pharmaceuticals's OCF Margin % or its related term are showing as below:


During the past 13 years, the highest OCF Margin % of Biodexa Pharmaceuticals was -694.11%. The lowest was -2711.35%. And the median was -1023.91%.

BDRX's OCF Margin % is not ranked *
in the Biotechnology industry.
Industry Median: -68.59
* Ranked among companies with meaningful OCF Margin % only.

Biodexa Pharmaceuticals OCF Margin % Related Terms

Biodexa Pharmaceuticals OCF Margin % Historical Data

* Premium members only.

The historical data trend for Biodexa Pharmaceuticals's OCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Biodexa Pharmaceuticals OCF Margin % Chart

Biodexa Pharmaceuticals Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
OCF Margin %
Get a 7-Day Free Trial Premium Member Only Premium Member Only -1,038.88 -1,008.81 -1,792.74 0.00 0.00

Biodexa Pharmaceuticals Semi-Annual Data
Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
OCF Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -3,550.48 0.00 0.00 0.00 0.00
BDRX
45GF Score
Biodexa Pharmaceuticals PLC BDRX
OCF Margin % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Biodexa Pharmaceuticals OCF Margin % Calculation

OCF Margin % is the ratio of Cash Flow from Operations divided by net sales or Revenue, usually presented in percent.

Biodexa Pharmaceuticals's OCF Margin for the fiscal year that ended in Dec. 2025 is calculated as

OCF Margin=Cash Flow from Operations (A: Dec. 2025 )/Revenue (A: Dec. 2025 )
=-7.485/0
= %

Biodexa Pharmaceuticals's OCF Margin for the quarter that ended in Dec. 2025 is calculated as

OCF Margin=Cash Flow from Operations (Q: Dec. 2025 )/Revenue (Q: Dec. 2025 )
=-3.062/0
= %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about OCF Margin % →
What does a OCF Margin % of 0.00% mean?
Biodexa Pharmaceuticals (BDRX) has a OCF Margin % of 0.00% as of Dec. 2025. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on Biodexa Pharmaceuticals and its competitors. According to the industry distribution chart, Biodexa Pharmaceuticals ranks #999999 out of 960 companies in the Biotechnology industry.
Is Biodexa Pharmaceuticals' OCF Margin % too high?
Biodexa Pharmaceuticals' current OCF Margin % is 0.00%. Based on the distribution chart, Biodexa Pharmaceuticals ranks #999999 out of 960 companies in the Biotechnology industry, which is in the bottom quartile relative to peers. Overall, Biodexa Pharmaceuticals has a GF Score™ of 45/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Biodexa Pharmaceuticals' OCF Margin % compare to CASIF and OGEN?
According to the Biotechnology industry distribution chart, Biodexa Pharmaceuticals ranks #999999 out of 960 companies for OCF Margin %. This places Biodexa Pharmaceuticals in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good OCF Margin % for a Biotechnology company?
A good OCF Margin % depends on the Biotechnology industry context. However, OCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high OCF Margin % mean?
A high OCF Margin % can signal that a stock is expensive relative to its fundamentals. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on Biodexa Pharmaceuticals and its competitors. Biodexa Pharmaceuticals's current OCF Margin % is 0.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Biodexa Pharmaceuticals stock overvalued right now?
Based on GuruFocus' analysis, Biodexa Pharmaceuticals (BDRX) is currently considered Fairly Valued. The stock's GF Value™ is $2.26, compared to a current price of $2.54 — trading 12.4% above its estimated fair value. The current OCF Margin % is 0.00%. Biodexa Pharmaceuticals' overall GF Score™ is 45/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is OCF Margin % calculated?
OCF Margin % is calculated from a company's financial statements. For Biodexa Pharmaceuticals (BDRX), the current OCF Margin % is 0.00% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Biodexa Pharmaceuticals (BDRX) Overvalued in 2026?

Based on GuruFocus' analysis, Biodexa Pharmaceuticals stock appears to be overvalued. The current stock price of $2.54 is trading 12.4% above its estimated GF Value™ of $2.26. GuruFocus considers Biodexa Pharmaceuticals to be Fairly Valued.

Key valuation signals for BDRX:

  • OCF Margin %: 0.00%
  • GF Value™: $2.26 vs. price of $2.54 (12.4% above fair value)
  • GF Score™: 45/100

No single metric tells the full story. See the BDRX stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Biodexa Pharmaceuticals Business Description

Address 1 Caspian Point, Caspian Way, Cardiff, GBR, CF10 4DQ
Biodexa Pharmaceuticals PLC is a clinical-stage biopharmaceutical company focused on developing a pipeline of products to treat diseases that have unmet medical needs. These include familial adenomatous polyposis (FAP), non-muscle invasive bladder cancer (NMIBC), type 1 diabetes (T1D), and rare or orphan brain cancers.
45GF Score

Get the complete analysis for BDRX

OCF Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$2.54
Price
$2.26
GF Value